New Data Sources Can Help Pharma Meet Challenges

At the Citeline Elevate Spring 2025 event, industry leaders convened to explore the future of pharmaceuticals through the lens of clinical and technological innovation. Claire Riches, VP of Clinical Solutions at Citeline, addressed industry challenges akin to those faced during the COVID-19 pandemic, advocating for proactive strategies leveraging real-world data (RWD) and artificial intelligence (AI). Dan Chancellor from Norstella revealed a significant 145% increase in active drug development, emphasizing the rising influence of biotech firms and global R&D shifts, particularly in China. Liz McCann highlighted the integration of AI and RWD in clinical planning, showcasing tools like Citeline PatientMatch and the AI chatbot Ella to enhance patient recruitment.

Read further on the discussions panelists touched on throughout this event and how it underscored the transformative potential of technology in shaping the pharmaceutical landscape.